Recruitment

Recruitment Status
Completed

Inclusion Criteria

Infant is ≤14 days old on day of enrollment
Having obtained his/her parents'/legal representative's informed consent
Birth weight ≥2500 g and ≤4500 g
...
Infant is ≤14 days old on day of enrollment
Having obtained his/her parents'/legal representative's informed consent
Birth weight ≥2500 g and ≤4500 g
Gestational age ≥37 weeks (full term infants)
Singleton birth
Healthy newborn infant

Exclusion Criteria

Infant undergoing antibiotic therapy.
Having any significant pre-natal and/or post-natal disease and/or congenital illness or malformation that may affect normal growth.
Re-hospitalization for more than 2 days in the first 14 days of life.
...
Infant undergoing antibiotic therapy.
Having any significant pre-natal and/or post-natal disease and/or congenital illness or malformation that may affect normal growth.
Re-hospitalization for more than 2 days in the first 14 days of life.
Parents not expected to comply with the protocol during the period of study participation.
Infants currently participating in another trial

Summary

Conditions
Infant Growth
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Participation Requirements

Age
Younger than 14 years
Gender
Both males and females

Inclusion Criteria

Infant is ≤14 days old on day of enrollment
Having obtained his/her parents'/legal representative's informed consent
Birth weight ≥2500 g and ≤4500 g
...
Infant is ≤14 days old on day of enrollment
Having obtained his/her parents'/legal representative's informed consent
Birth weight ≥2500 g and ≤4500 g
Gestational age ≥37 weeks (full term infants)
Singleton birth
Healthy newborn infant

Exclusion Criteria

Infant undergoing antibiotic therapy.
Having any significant pre-natal and/or post-natal disease and/or congenital illness or malformation that may affect normal growth.
Re-hospitalization for more than 2 days in the first 14 days of life.
...
Infant undergoing antibiotic therapy.
Having any significant pre-natal and/or post-natal disease and/or congenital illness or malformation that may affect normal growth.
Re-hospitalization for more than 2 days in the first 14 days of life.
Parents not expected to comply with the protocol during the period of study participation.
Infants currently participating in another trial

Tracking Information

NCT #
NCT02111837
Collaborators
Not Provided
Investigators
  • Principal Investigator: Claude Billeaud, MD Hôpital des enfants, CHU Pellegrin, Bordeaux, France
  • Claude Billeaud, MD Hôpital des enfants, CHU Pellegrin, Bordeaux, France
About Us
Innovation
Privacy
Terms
Copyright
Get Well Soon © Copyright 2024